World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
66
Citations
22165
World Ranking
2354
National Ranking
56

Fabrizio Conti publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Fabrizio Conti sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 468 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Fabrizio Conti D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Fabrizio Conti sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 66 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Fabrizio Conti is affiliated with Sapienza University of Rome in Italy, focusing primarily on the field of Medicine with a considerable emphasis on Rheumatology, Immunology, Pathology and Forensic Medicine, Infectious Diseases, and Hematology. Their research addresses complex medical conditions, with an extensive body of work encompassing 543 publications in medicine and 198 specifically in rheumatology.

The researcher's main topics of study include systemic lupus erythematosus, rheumatoid arthritis, autoimmune and inflammatory disorders, systemic sclerosis, spondyloarthritis, monoclonal and polyclonal antibodies, and SARS-CoV-2 including COVID-19. This range highlights a focus on immune-mediated diseases and related therapeutic approaches, intersecting with infectious disease research during the COVID-19 pandemic.

Fabrizio Conti's recent papers illustrate this thematic diversity:

  • "COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?" (2020), published in Autoimmunity Reviews
  • "HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19" (2020), published in Science Immunology
  • "Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting" (2020), published in Arthritis & Rheumatology
  • "Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma" (2021), published in Journal of Hepatology
  • "SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists" (2021), published in Annals of the Rheumatic Diseases

Their collaborative network includes frequent co-authors such as Fulvia Ceccarelli, Cristiano Alessandri, Francesca Romana Spinelli, Simona Truglia, and Roberta Priori. This team approach suggests active engagement in multi-author studies and ongoing partnerships in rheumatology and immunology research.

Fabrizio Conti has contributed substantially to a number of prominent journals, with the most frequent publication venues being:

  • Annals of the Rheumatic Diseases (78 publications)
  • Clinical and Experimental Rheumatology (27 publications)
  • Lara D. Veeken (16 publications)
  • Lupus (13 publications)
  • Autoimmunity Reviews (7 publications)

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

    Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif

  • COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?

    Serena Colafrancesco;Cristiano Alessandri;Fabrizio Conti;Roberta Priori

  • Smoke and autoimmunity: The fire behind the disease.

    Carlo Perricone;Mathilde Versini;Dana Ben-Ami;Smadar Gertel

  • Anti-β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts

    Maurizio Sorice;Agostina Longo;Antonella Capozzi;Tina Garofalo

  • 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.

    Ricard Cervera;Ignasi Rodríguez-Pintó;Serena Colafrancesco;Fabrizio Conti

  • Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

    Lorenzo Cavagna;Ernesto Trallero-Araguás;Federica Meloni;Ilaria Cavazzana

  • Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus.

    Alessandra Bortoluzzi;Carlo A lberto Scirè;Stefano Bombardieri;Luisa Caniatti

  • T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy

    Cristiano Alessandri;Cristiana Barbati;Davide Vacirca;Paola Piscopo

  • International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management

    Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Chiara Baldini

  • Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases

    Carlo Perricone;Fulvia Ceccarelli;Gideon Nesher;Elisabetta Borella

  • Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.

    Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Elena Bartoloni-Bocci

  • Infliximab Treatment for Ocular and Extraocular Manifestations of Behçet's Disease

    Massimo Accorinti;Maria Pia Pirraglia;Maria Pia Paroli;Roberta Priori

  • Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies

    Fabrizio Conti;Cristiano Alessandri;Daniela Bompane;Michele Bombardieri

  • Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.

    Ugo Ramenghi;Sara Bonissoni;Sara Bonissoni;Sara Bonissoni;Giuseppe Migliaretti;Giuseppe Migliaretti;Giuseppe Migliaretti;Simona DeFranco;Simona DeFranco;Simona DeFranco

  • Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients

    Marcello Govoni;Stefano Bombardieri;Alessandra Bortoluzzi;Luisa Caniatti

  • Vaccination and autoimmune rheumatic diseases

    Fabrizio Conti;Soheila Rezai;Guido Valesini

  • Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry

    Luca Iaccarino;Elena Bartoloni;Linda Carli;Fulvia Ceccarelli

  • Switching tumour necrosis factor α antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period

    Fabrizio Conti;Fulvia Ceccarelli;Elisa Marocchi;Leonardo Magrini

  • HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19.

    Francesca Romana Spinelli;Fabrizio Conti;Massimo Gadina

  • Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.

    Fabrizio Conti;Cristiano Alessandri;Carlo Perricone;Rossana Scrivo

  • Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome.

    Elena Ortona;Antonella Capozzi;Tania Colasanti;Fabrizio Conti

Frequent Co-Authors

Guido Valesini
Guido Valesini Sapienza University of Rome
Carlo Perricone
Carlo Perricone University of Perugia
Maurizio Sorice
Maurizio Sorice Sapienza University of Rome
Andrea Doria
Andrea Doria University of Padua
Elena Ortona
Elena Ortona Istituto Superiore di Sanità
Valeria Riccieri
Valeria Riccieri Sapienza University of Rome
Elisa Gremese
Elisa Gremese Catholic University of the Sacred Heart
Roberto Caporali
Roberto Caporali University of Milan
Angela Tincani
Angela Tincani University of Brescia
Giuseppe Novelli
Giuseppe Novelli University of Rome Tor Vergata

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various online healthcare programs that cater to diverse healthcare interests and career goals. For those looking to expand their qualifications, exploring online healthcare programs can provide flexible learning options in fields related to microbiology and medical sciences.

Additionally, public health is a natural extension for microbiology graduates. Many find value in enrolling in easy MPH online programs that allow for convenient specialization in epidemiology, biostatistics, or environmental health, enhancing their ability to impact community health.

Career paths such as becoming a child life specialist, which combines healthcare knowledge with patient interaction, also appeal to microbiology graduates interested in pediatric care. Understanding the child life specialist salary and job requirements can help students assess opportunities in this rewarding field.

Moreover, microbiology students seeking fresh starts or alternative entry points into medical careers might consider degrees highlighted in the best associate degrees for felons resource. This guide showcases accessible, career-oriented programs that support inclusivity and new beginnings.

Best Scientists Citing Fabrizio Conti

Trending Scientists

Recently Published Articles